Amit C. Achhra

684 citations

26 papers · 485 indexed · h-index 13

Impact in

Virology top 2%
- HIV Research and Treatment
Emergency Medicine top 2%
- HIV-related health complications and treatments

Papers in

Virology 13
- HIV Research and Treatment 13
Emergency Medicine 15
- HIV-related health complications and treatments 15

Co-authors: Janaki Amin Mark Boyd Matthew Law Sean Emery Amanda Mocroft Lene Ryom Alan Landay Roberto C. Arduino
Journals: AIDS (3 papers)Current HIV/AIDS Reports (2 papers)HIV Medicine (2 papers)Current Opinion in HIV and AIDS (2 papers)Clinical Infectious Diseases (1 paper)
Partner nations: Australia United States United Kingdom

In The Last Decade

Amit C. Achhra

23 papers receiving 469 citations

Peers

Countries citing papers authored by Amit C. Achhra

Since Specialization

Citations

This map shows the geographic impact of Amit C. Achhra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amit C. Achhra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amit C. Achhra more than expected).

Fields of papers citing papers by Amit C. Achhra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amit C. Achhra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amit C. Achhra. The network helps show where Amit C. Achhra may publish in the future.

Co-authors

The 25 scholars most cited alongside Amit C. Achhra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Amit C. Achhra Line = papers co-authored together Amit C. Achhra links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Five-Year Evaluation of an Anal Cancer Screening Program in Men Who Have Sex With Men With HIV at 2 Academic Center Clinics Clinical Infectious Diseases ·Amit C. Achhra, Ивашин Иван Леонидович, 宣一會澤, 钟子炎, Н Н Силищев, Yasushi Kojo, Ondřej Budík, Shao JuNan, Lydia Barakat	2024	1
2	Acute Hepatitis due to Primary Human Immunodeficiency Virus Infection Open Forum Infectious Diseases ·Eric I. Elliott, Ana Isabel Ribeiro da Costa Marinho, Jonathan Lipscomb, Bubu A. Banini, Meridith L Smith, Thomas H. Vanderford, Jeffrey Alan Johnson, Dhanpat Jain, Amit C. Achhra	2024	0
3	Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV Kidney International ·Annegret Pelchen–Matthews, Amanda Mocroft, Lene Ryom, Michael J. Ross, Shweta Sharma, Steven G. Coca, Amit C. Achhra, Elaine Cornell, Russell P. Tracy, Andrew Phillips, Marta Montero, N.G. Cole, Brian K. Agan, Nicholas Medland, Christina Wyatt	2024	0
4	Contrasting Cases of HIV Vasculopathy Associated Fusiform Aneurysms The Neurohospitalist ·F. J. Aparicio, 李丹阳, Amit C. Achhra, Nagagopal Venna	2022	0
5	Assessing Cardiovascular Risk in People Living with HIV: Current Tools and Limitations Current HIV/AIDS Reports ·Amit C. Achhra, Asya Lyass, Leila H. Borowsky, Masahiro Ayabe, Jorge Plutzky, Joseph M. Massaro, Ralph B. D’Agostino, Virginia A. Triant	2021	35
6	Sex‐based differences in antiretroviral therapy initiation, switching and treatment interruptions: global overview from the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Journal of the International AIDS Society ·Michelle Giles, Amit C. Achhra, Alison G. Abraham, Andreas D. Haas, M. John Gill, Man Po Lee, Л Ф Суходоева, Catherine C. McGowan, Morna Cornell, Paula Braitstein, Nathalie de Rekeneire, Renaud Becquet, Kara Wools‐Kaloustian, Matthew Law	2018	16
7	Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV‐Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial Journal of the American Heart Association ·Jason V. Baker, Shweta Sharma, Amit C. Achhra, José Ignacio Bernardino, Johannes R. Bogner, Daniel Duprez, Sean Emery, Brian Gazzard, Aramaki Eiji, Greg Grandits, Andrew Phillips, Siegfried Schwarze, Elsayed Z. Soliman, Stephen A. Spector, Giuseppe Tambussi, Jens Lundgren, (unknown)	2017	48
8	Impact of early versus deferred antiretroviral therapy on estimated glomerular filtration rate in HIV-positive individuals in the START trial International Journal of Antimicrobial Agents ·Amit C. Achhra, Amanda Mocroft, Michael J. Ross, Oxana Alexandrovna Ovsyannikova, Anchalee Avihingsanon, Elżbieta Bąkowska, Waldo Belloso, Amanda Clarke, Hansjakob Furrer, Gregory M. Lucas, Matti Ristola, Mohammed Rassool, Jonathan Ross, Charurut Somboonwit, Shweta Sharma, Christina Wyatt	2017	15
9	Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments Current HIV/AIDS Reports ·Amit C. Achhra, S. Roslyn, Amanda Mocroft, Lene Ryom, Christina Wyatt	2016	35
10	Efficacy and safety of contemporary dual-drug antiretroviral regimens as first-line treatment or as a simplification strategy: a systematic review and meta-analysis The Lancet HIV ·Amit C. Achhra, Kangqi Ni, Janaki Amin, Mark Boyd	2016	38
11	Plasma levels of cytokines and chemokines and the risk of mortality in HIV-infected individuals AIDS ·Martyn A. French, Alessandro Cozzi‐Lepri, Roberto C. Arduino, Margaret Johnson, Amit C. Achhra, Alan Landay	2015	46
12	Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial HIV Medicine ·Maria Eduarda Pacheco Pires, Shweta Sharma, Keikawus Arastéh, David A. Wohl, Amit C. Achhra, Giuseppe Tambussi, Jemma L. O’Connor, James H. Stein, Sophia Möller, Sinai Choi, Andrew Phillips, (unknown)	2015	27
13	Clinical and demographic factors associated with low viral load in early untreated HIV infection in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial HIV Medicine ·Matthew Law, Amit C. Achhra, Steven G. Deeks, Brian Gazzard, Sarki, 千咲子宮島, Matti Ristola, (unknown)	2015	6
14	Moving Away from Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE) - Agents That Concern Prescribers and Patients: A Feasibility Study and Call for a Trial PLoS ONE ·Amit C. Achhra, Mark Boyd, Matthew Law, Gail Matthews, Anthony D. Kelleher, David A. Cooper	2014	4
15	Relationship between CD4 cell count and serious long-term complications among HIV-positive individuals Current Opinion in HIV and AIDS ·Amit C. Achhra, Kathy Petoumenos, Matthew Law	2013	13
16	Antiretroviral regimens sparing agents from the nucleoside(tide) reverse transcriptase inhibitor class: a review of the recent literature AIDS Research and Therapy ·Amit C. Achhra, Mark Boyd	2013	24
17	Reclassification of risk of death with the knowledge of D-dimer in a cohort of treated HIV-infected individuals AIDS ·Amit C. Achhra, Janaki Amin, Caroline Sabin, Haitao Chu, David Dunn, Lewis H. Kuller, Joseph A. Kovacs, David A. Cooper, Sean Emery, Matthew Law	2012	8
18	Long-term immunological outcomes in treated HIV-infected individuals in high-income and low-middle income countries Current Opinion in HIV and AIDS ·Amit C. Achhra, Praphan Phanuphak, Janaki Amin	2011	11
19	Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients AIDS ·Amit C. Achhra, Janaki Amin, Matthew Law, Sean Emery, Jan Gerstoft, Fred M. Gordin, Michael J. Vjecha, James D. Neaton, David A. Cooper	2010	62
20	Difference in Absolute CD4+ Count According to CD4 Percentage between Asian and Caucasian HIV-Infected Patients Journal of AIDS & Clinical Research ·Amit C. Achhra, Jialun Zhou, François Dabis, Sanjay Pujari, Rodolphe Thiébaut	2010	30

About Amit C. Achhra

Amit C. Achhra is a scholar working on Virology, Emergency Medicine, Infectious Diseases, Pharmacy and Rheumatology, having authored 26 papers that have together received 485 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (19 papers), HIV/AIDS drug development and treatment (16 papers), HIV-related health complications and treatments (15 papers), HIV Research and Treatment (13 papers), Moyamoya disease diagnosis and treatment (1 paper), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper), Bone and Joint Diseases (1 paper) and Neurological Complications and Syndromes (1 paper). The work is most often cited by research in Virology (226 citations), Emergency Medicine (297 citations), Infectious Diseases (330 citations), Epidemiology (89 citations) and Hepatology (18 citations). Amit C. Achhra has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Janaki Amin, Mark Boyd, Matthew Law, Sean Emery, Amanda Mocroft, Lene Ryom, Alan Landay, Roberto C. Arduino, Christina Wyatt and Alessandro Cozzi‐Lepri. Their work appears in journals such as AIDS, Current HIV/AIDS Reports, HIV Medicine, Current Opinion in HIV and AIDS and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact